Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV

Today the Net Asset Value of the P Capital Partners IV participation loan debentures is being announced. At the close of business on 3 September 2021, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 103.92 each. The Net Asset Value of P Capital Partners IV participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set, as P Capital Partners IV has increased its contributed capital by EUR 15.5 million, through the issuance of 154,240 series A1

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV B

Today the Net Asset Values of the P Capital Partners IV B participation loan debentures are being announced. At the close of business on 3 September 2021, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 103.14 each, and the Net Asset Value of the series B participation loan debenture amounted to EUR 1,032.07 each. The Net Asset Value of P Capital Partners IV B participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set, as P Capital Partners IV

Laura Chirica appointed new Board Director in Gradientech

Uppsala, 6 September 2021. The Extra General Meeting at the diagnostic company Gradientech today elected Laura Chirica new Board Director. Laura has 20 years of experience from leading positions within life science, bio process and diagnostic companies, and is currently Chief Commercial Officer at Immunovia AB.“Laura Chirica has played a key role in the commercialization of Immunovia’s first product, being part of the company’s journey from the beginning until reaching market. During these years, Immunovia was approved for trading in 2015 on Nasdaq First North in Stockholm followed by

Orkla ASA - Contemplating senior unsecured NOK bond issuance

Orkla ASA has mandated Danske Bank, DNB Markets and Nordea as Joint Lead Managers for one or more senior unsecured bond issues. Subject to market conditions, bond issues with tenors of minimum 5.5 years, and a combined expected deal size of NOK 1 billion may follow.Orkla ASA Oslo, 6 September 2021   Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789   This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Azelio is granted two patents for its long-duration energy storage technology

Azelio has two new patents published. The patents have been granted in the USA and China as well as in Sweden and are related to the function of the thermal energy storage and power conversion as well as the transfer of stored energy to electricity and heat generation. Azelio now has 16 granted patents and several patents under registration.The patent granted in Sweden describes the energy storage system TES.POD's function of the thermal storage and the charging and discharging system as well as the power conversion unit. This patent protects Azelio's energy storage system TES.POD, which

New Managing Director in Atea Norway

Ole Petter Saxrud has been appointed as Managing Director in Atea Norway, effective immediately. He replaces Michael Jacobs, who is leaving Atea.  We want to thank Michael for his contribution to the development of Atea. Ole Petter joined Atea in March 2020 as General Manager of Region East in Norway.  Region East is the largest region in Norway, covering Oslo and the surrounding population. In addition, Ole Petter has had overall responsibility for the professional services business in Norway during the past year.  Prior to joining Atea, Ole Petter worked for the IT consultancy Sopra

Musti Group strengthens its ecosystem with new digital services

Musti Group plc                        Press Release 6 September 2021 at 9.30 a.m. Musti Group strengthens its ecosystem with new digital services Musti Group’s mission is to make the life of pets and their parents easier, safer and more fun throughout the whole lifespan of the pet. In addition to the product offering, we want to provide the customers with full experience of services – both physical and digital. The customer growth continues strong. In June-August 2021, the number of new puppy customers grew by 35% compared to same period previous year. Musti Group is building an

Arjo receives 510(k) clearance from US FDA for WoundExpress

Arjo has received 510(k) clearance from the US Food and Drug Administration (FDA) for WoundExpress, an intermittent pneumatic compression (IPC) solution for accelerating healing of venous leg ulcers. The FDA clearance follows several recent studies showing that WoundExpress can significantly improve lower leg wound management. “This is an important milestone for us and we see great potential in now bringing this innovative therapy to the US market as well”, says Joacim Lindoff, President & CEO of Arjo. “Venous leg ulcers are a rapidly growing and costly problem for healthcare, with

Cereno Scientific obtains patents in 15 European countries solidifying CS1’s protection

Cereno Scientific (XSAT: CRNO B) today announced that CS1’s first patent family has been granted patents in 15 European countries following a completed validation and opposition period. This adds to the already granted markets that include Australia, Canada, Japan, and the US, thus securing patent protection for CS1 in nearly all global key markets.“It is great to obtain our first patent for CS1 in Europe. Adding this market to the already granted markets offers a good broad patent protection, which is generally an important factor when looking at an asset’s commercial potential,” said Sten

SyntheticMR signs global agreement with Philips to include SyntheticMR’s solution in third party product catalogue

SyntheticMR has entered an agreement with Philips to include SyntheticMR’s medical imaging solution in their global product catalogue. The agreement means that SyntheticMR’s solution SyMRI NEURO will be included in Philips’ third-party product catalogue and enables Philips to offer the complete package to their customers.SyntheticMR’s software solution for MR imaging, SyMRI NEURO, enables more efficient workflows and supports more precise diagnosis of patients. Philips currently offers the quantitative MR sequence SyntAc as an option to their customers, which in combination with SyntheticMR’

Realheart´s new animal studies are about to start

Realheart is developing the world's first artificial four-chambered heart. The research and development work are conducted using three different methods: digitally, in the laboratory and through anatomical and animal studies. In September, the long-term animal studies continue after a break during the summer, while digital tests and laboratory studies continue in parallel.Digital studies include virtual implantations in 3D models based on real patients – an altogether new way of working in medical technology and one that Realheart is the first user to try – in collaboration with German

ExpreS2ion announces TO5 warrant exercise price and start of subscription period

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Hørsholm, Denmark, September 06, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion" or the “Company”) announces that the exercise price for the warrants of series TO5 has been determined to SEK 25.00 and the subscription period starts

Scandion Oncology receives approval for initiating the CORIST part 2 trial

Scandion Oncology A/S, the Cancer Drug Resistance Company, today announced that the company has obtained approval from the Danish Medicines Agency and the Ethics Com-mittee in Denmark of the amendment of part 2 of the CORIST Phase II study. This means that the company can commence the inclusion of patients. To increase the recruitment rate, Scandion Oncology is expanding the number of sites in Denmark from 2 to 5 and will further add additional sites in the EU.“With this approval, we can now commence part 2 of this seminal study. This next step in our journey will target a clear proof-of-

Veoneer products enable level 3 hands-off self-driving tech

Stockholm, Sweden, September 6, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), is proud contributor to the Highly Automated Driving solution in the Mercedes-Benz S-class, equipped to offer level 3 hands-off self-driving tech.During the fall, Mercedes-Benz' DRIVE PILOT system is being introduced with greater performance from Veoneer’s Stereo Vision and Radar products to support level 3 self-driving. Veoneer’s 4[th] generation stereo vision camera system is comprised of fully integrated hardware and perception software to master the challenges of highly

Storytel appoints Johan Ståhle and Mark Pasternak as Head of Product and Head of Technology

Storytel appoints Mark Pasternak as Head of Technology and Johan Ståhle as Head of Product. Together they will lead Storytel’s tech teams and the development of the company’s platform, products and customer experience.Johan Ståhle comes from an entrepreneurial background leading product development and scaling digital business in the fintech and management consulting sectors. Johan is the co-founder and former Chief Product Officer of the Nordic fintech company Dreams and has also been Expert Engagement Manager at McKinsey. “I love the energy, focus and the fast pace of entrepreneurial

The exercise period for the warrants of series TO 1 begins today, September 6, 2021

Today, September 6 2021, the exercise period begins for the warrants of series TO 1 that were issued during Nexam Chemical Holding AB’s (“Nexam Chemical” or “the Company”) issuing of units in February 2020.The exercise period beings today, September 6 2021, and will continue up to and including September 17, 2021. Each warrant of series TO 1 entitles the holder to subscribe for one (1) new share at a subscription price of SEK 6.50 per share. If all warrants are exercised, the Company will receive approximately SEK 13.5 million before issuing costs. Holders of warrants must actively

Halton’s sustainable kitchen ventilation solutions installed in the restaurants of La Samaritaine department store in Paris

La Samaritaine department store in Paris, the icon of the Art Nouveau and Art Deco movements, sparkles again. After a seven-year renovation and 750 million euros to restore the splendor of this unique 111 year old building which now comprises luxury shops, stores of small French fashion labels, restaurants, offices, The Cheval Blanc five stars hotel, social housing and even a nursery. Halton designed, delivered, and commissioned the state-of-the-art kitchen ventilation solutions for 6 restaurants, from Ernest boulangerie bar restaurant to Le Cheval Blanc fine dining restaurant, headed by the

Climate change and health: developing evidence for action

Media invitation 15 September: Gordon Goodman Memorial Lecture with Professor Andy Haines The Royal Swedish Academy of Sciences, Stockholm Environment Institute (SEI) and Stockholm University are proud to present the Gordon Goodman Memorial Lecture given by Professor Sir Andy Haines on 15 September 2021. The lecture will focus on a crucial topic: the direct and indirect ways in which climate change impacts human health and solutions that can yield multiple co-benefits for people and the environment.Sir Andy Haines is Professor of Environmental Change and Public Health at the London

SBB and Alive take responsibility for sustainable housing with 30 per cent lower rents

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) and the concept company Alive Bostad AB (“Alive”) are building 162 homes aimed at young adults. SBB will be the long-term owner of the homes. Through the Alive concept, the rent will be approximately 30 percent lower. Alive offers quality apartments with a high standard to young adults aged 18-35. Initially, 162 rent regulated residentials are being built in Uppsala and Rosendal. In these apartments, rents are 30 per cent lower compared to other new construction. Completion is estimated to take place in December 2022. Sustainable

Former finance minister and industry veteran join the board of Aker Offshore Wind and Hexicon’s new Swedish JV

Oslo/Stockholm, 6 September 2021: Aker Offshore Wind and Hexicon have today appointed former Swedish Finance Minister Pär Nuder and former Vattenfall executive Mikael Kramer to the Board of Directors of its new 50-50 joint venture to develop floating wind offshore Sweden.With Sweden’s plans to produce 100 percent of its energy from renewable sources by 2040 and to achieve carbon neutrality by 2045, the partners see a clear opportunity for offshore wind projects as the market develops. The board of directors for the joint venture includes Swedish nationals Pär Nuder and Mikael Kramer.

New lets on Avenyn

Through an innovative and smart reallocation of floor space, Wallenstam’s tenants on Avenyn can expand their businesses. Lindex and Kvarterskliniken are growing into both new and larger areas and the successful data consulting firm Logikfabriken is choosing Wallenstam and Avenyn for its new office.In Kopparhuset at Kungsportsavenyen 33, Lindex is expanding its retail space on the ground floor.  The previous retail space on the second floor is now being reconstructed for Kvarterskliniken, which is leasing an additional 640 square meters. “For a long time we have had the ambition to open a

Duni Group first in the world to use fossil free propane gas in paper production – a major step towards a 90-per-cent lower climate footprint

Duni Group’s journey towards fossil-free operations continues as the first fossil free propane gas (BioLPG) delivery arrived at the subsidiary Rexcell Tissue & Airlaid’s paper mill in Skåpafors, Sweden. The transition to BioLPG produced from waste products primarily from the food industry is a major step forward towards an increasingly circular business model and a lower climate impact. Duni Group is therefore the first company in the world within the paper industry to use LPG physically produced from fully renewable raw materials, enabled by a collaboration with Kosan Gas."The transition

Skanska builds 121 apartments in Bærum, Norway for NOK 480M, about SEK 475M

Skanska has signed an agreement with OBOS to build 121 apartments in Bærum, Norway. The contract is worth approximately NOK 480M, about SEK 475M, which will be included in the Nordic order bookings for the third quarter of 2021.The project is a pilot in The FutureBuild program in Norway and has high environmental ambitions. There will be high use of eco-friendly solutions that consume little energy and leave as small climate footprint as possible (e.g. low carbon concrete). The overall goal is to reduce greenhouse gas emissions by between 30 and 50 percent. Skanska has participated in

Completion of share buy back offer

Reference is made to the notice issued on 30 August 2021, where Otello Corporation ASA launched an offer to all shareholders to buy back up to 12,450,000 shares, through a book building process. The Company has today bought 12,450,000 shares in the Company at a price of NOK 33.00 per share. Otello was offered 41,770,904 shares at the clearing price and thus allocated approximately 29.8% to shareholders which tendered at NOK 33.00 and below.  Following the transaction, Otello Corporation ASA owns 12,450,000­­­ shares in the Company. The Board will call for an EGM and propose that

There are no items matching the current filter
There are no more items matching the current filter
Back to top